Reporter

Jonathan Saltzman

Jonathan Saltzman has worked at the Boston Globe since 2002 and currently covers biotechnology and the life sciences. He previously covered the federal and state courts and then spent six years on the Spotlight Team. He was part of a team that won a George Polk Award in 2012 for a series on the state’s unusually high rate of acquittal at bench trials for drunk driving. He was also a runner-up for other awards, including a Pulitzer Prize and Goldsmith Prize for Investigative Reporting, for a series of stories about dangerous off-campus housing for college students in Boston. Saltzman, a graduate of Brooklyn College, has worked at the Providence Journal, USA Today, the Rochester Democrat & Chronicle, and the Poughkeepsie Journal. He also co-hosted a daily magazine show for the NPR station in Rhode Island. He lives in Providence.

Latest stories

Biogen halts late-stage trials on Alzheimer’s drug

By Felice J. Freyer, and Adam Feuerstein , Globe Staff | STAT

The Cambridge biotech and its Japanese partner concluded the drug was unlikely to benefit patients. Patients and families with dementia were discouraged by the announcement.

Flagship Pioneering raises $824m in VC round, its most ever

By , Globe Staff

The Cambridge firm said the money will be used to further boost companies it’s already launched.

Boston biotech working on schizophrenia treatment raises $68 million

By , Globe Staff

Karuna Therapeutics says its drug would minimize side effects.

Marijuana treatment could act as ‘sexual enhancement’

By , Globe Staff

A Worcester startup is working with a Los Angeles urologist who oversaw clinical trials of Viagra and Cialis on a new product that they hope could help women’s sex lives.